-transparent.png){kind=logo}
Recombinant interleukin-1 (rIL-1) is known to inhibit glucose-induced insulin secretion by islets of Langerhans, a novel target tissue of cytokine. We have investigated whether rIL-1 pretreatment affects biochemical mechanisms known to be involved in the regulation of Ca2+ homeostasis during glucose-induced insulin secretion. Glucose-induced Ca2+ uptake by intact islets through the plasma membrane was dramatically inhibited (96%) by rIL-1 (2 nM). rIL-1, however, did not affect Ca2+ uptake by, or Ins 1,4,5-P3-induced Ca2+ efflux from, the endoplasmic reticulum in digitonin-permeabilized islets, although glucose-induced accumulation of inositol trisphosphates was inhibited (38%). These results suggest that perturbation of intracellular Ca2+ homeostasis in islets is involved in inhibition of insulin secretion by rIL-1.
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
June 1994,
The American journal of physiology,
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
September 1990,
Transplantation,
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
January 2001,
European cytokine network,
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
June 1978,
Endocrinology,
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
August 1993,
Diabetes,
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
July 1976,
Diabetologia,
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
January 1971,
Endocrinology,
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
January 2017,
Journal of diabetes research,
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
December 1989,
FEBS letters,
B A Wolf, and
J H Hughes, and
J Florholmen, and
J Turk, and
M L McDaniel
July 1994,
The Journal of biological chemistry,
